The company develops innovative compounds that that RNA of cancer-driven genes. Its lead compound, currently advancing into the clinical phase, targets the treatment of malignant mesothelioma, a disea...
The Insud Pharma group has announced the winners of the V edition of its ChemoStart programme. The biotech companies Aromics and MiMark Diagnostics, based in the Barcelona Science Park, together with ...
InvestHorizon is a programme financed by the European Commission, in association with Eureka, to facilitate series A funding for selected deep tech companies boosting their investment readiness and...
The financial round of 300,000€ is oriented towards private investors who are interested in acquiring equity in the company through the European biotechnology crowdfunding platform CapitalCell who h...